Flerie’s portfolio company Chromafora acquires Montrose Environmental Group Denmark
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Flerie AB’s (publ) portfolio company Chromafora has acquired Montrose Environmental Group Denmark, a Danish specialist in PFAS and provider of technical solutions for contaminated water treatment. The acquisition strengthens the company’s offerings for treating PFAS-contaminated water streams, to a leading position in the field.
Montrose Environmental Group Denmark is well known for its technical skill and expertise in addressing complex water treatment challenges particularly in long chain PFAS. The acquisition complements Chromafora’s Selpaxt technology, which focuses on short and ultra-short PFAS providing a broader offering. The subsidiary will be named Chromafora Denmark ApS.
Through the acquisition, the parent company Montrose Environmental Group, Inc. becomes a strategic investor and shareholder in Chromafora.
“The acquisition will significantly accelerate Chromafora’s growth as it increases the company’s offering and client base. As part of Flerie’s active ownership strategy, we always strive to create the best possible owner structure for our portfolio companies. We are therefore very pleased with the transaction which brings Montrose as a strategic investor in Chromafora, opening the door to closer collaboration between the two companies to create substantial synergies and accelerate value creation for all stakeholders,” says Mark Quick, Partner at Flerie.
Read Chromafora’s full press release here: Chromafora acquires Montrose Environmental Group Denmark
Flerie’s ownership in Chromafora amounts to 28%.
What is PFAS?
PFAS, short for per- and polyfluoroalkyl substances, are a large group of human-made chemicals often called “forever chemicals” because they degrade very slowly in the environment. Due to their high persistence and ability to travel long distances, PFAS accumulate in water, soil, wildlife, and humans, resulting in widespread environmental contamination. Some PFAS have been linked to health concerns, prompting regulators to restrict PFAS use and set limits on PFAS levels in drinking water and other media.
For more information:
Mark Quick, Partner at Flerie
Email: ir@flerie.com
Flerie in brief
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie’s active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB’s ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com